The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells-Reference-Cited by-同舟云学术

The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells

Published:2014-03-20 Issue:4 Volume:61 Page:376-384
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Tang Ping¹²,Li Li³,Zhou Yan⁴,Shen Cong-Cong¹,Kang Yu-Huan¹,Yao Yu-Qin¹⁵,Yi Cheng⁶,Gou Lan-Tu¹,Yang Jin-Liang¹⁵

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center; West China Hospital; West China Medical School; Sichuan University; Chengdu People's Republic of China

2. Department of Biochemistry and Molecular Biology; West China School of Preclinical and Forensic Medicine; Sichuan University; Chengdu People's Republic of China

3. Department of Biophysics; School of Life Science and Technology; University of Electronic Science and Technology of China; Chengdu People's Republic of China

4. The Gastroenterology Tumor and Microenvironment Laboratory; Department of Gastroenterology; The First Affiliated Hospital of Chengdu Medical College; Chengdu Medical College; Chengdu People's Republic of China

5. Guangdong Zhongsheng Pharmaceutical Company Limited; Dongguan People's Republic of China

6. Division of Abdominal Cancer; Cancer Center; West China Hospital; West China Medical School; Sichuan University; Chengdu People's Republic of China

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bab.1187/fullpdf

Reference38 articles.

1. Tumor Angiogenesis The Future Is Now

2. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

3. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer;Cancers;2023-03-04

2. MCDA-DEA approach to construct a composite indicator for effluents from WWTPs considering the influence of PPCPs;Environmental Science and Pollution Research;2023-02-03

3. Unraveling pharmaceuticals removal in a sulfur-driven autotrophic denitrification process: Performance, kinetics and mechanisms;Chinese Chemical Letters;2023-02

4. Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer;International Journal of Molecular Sciences;2021-02-28

5. Potential of an estuarine salt marsh plant (Phragmites australis (Cav.) Trin. Ex Steud10751) for phytoremediation of bezafibrate and paroxetine;Hydrobiologia;2020-04-30